Skip to main content

Table 3 Self-reported adherence among ASCVD patients taking part in cross-sectional study in MSF clinics, north Lebanon

From: Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon

Drug Overall (%, 95CI) Abdeh clinic (%, 95 CI) DAZ clinic (%, 95 CI)
ACE-I 83.8 [79.1, 87.6] 90.8 [85.2, 94.5] 75.2 [67.1, 81.9]
Statin 78.4 [74.4, 81.9] 91.2 [86.5, 94.4] 67.7 [61.7, 73.1]
Antiplatelet 93.9 [91.3, 95.8] 95.6 [91.7, 97.7] 92.5 [88.5, 95.2]
β—blocker 90.8 [87.4, 93.4] 94.1 [75.2, 87.4] 88.3 [83.2, 92.1]
Statin, antiplatelet, ACE-I 69.5 [64.0, 74.6] 82.0 [75.2, 87.4] 54.4 [45.7, 62.8]
Statin, antiplatelet, ACE-I/BB 72.6 [67.2, 77.5] 85.2 [78.7, 90.0] 57.3 [48.5, 65.5]